137 related articles for article (PubMed ID: 19458320)
1. Immune responses to EBNA1: biomarkers in MS?
Lünemann JD; Ascherio A
Neurology; 2009 Jul; 73(1):13-4. PubMed ID: 19458320
[No Abstract] [Full Text] [Related]
2. Epstein-Barr virus and multiple sclerosis.
Lucas RM; Hughes AM; Lay ML; Ponsonby AL; Dwyer DE; Taylor BV; Pender MP
J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1142-8. PubMed ID: 21836034
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus and multiple sclerosis: interaction with HLA.
Sundqvist E; Sundström P; Lindén M; Hedström AK; Aloisi F; Hillert J; Kockum I; Alfredsson L; Olsson T
Genes Immun; 2012 Jan; 13(1):14-20. PubMed ID: 21776012
[TBL] [Abstract][Full Text] [Related]
4. Immune response induced by Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides in current and past infectious mononucleosis: a risk for multiple sclerosis?
Mameli G; Madeddu G; Cossu D; Galleri G; Manetti R; Babudieri S; Mura MS; Sechi LA
Eur J Neurol; 2016 Jan; 23(1):140-7. PubMed ID: 26453465
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: no.
Salzer J; Myhr KM
Mult Scler; 2013 Nov; 19(13):1692-3. PubMed ID: 24218487
[No Abstract] [Full Text] [Related]
6. Epstein-Barr virus.
Rickinson A
Virus Res; 2002 Jan; 82(1-2):109-13. PubMed ID: 11885937
[No Abstract] [Full Text] [Related]
7. EBV in MS: guilty by association?
Lünemann JD; Münz C
Trends Immunol; 2009 Jun; 30(6):243-8. PubMed ID: 19428300
[TBL] [Abstract][Full Text] [Related]
8. Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis.
Lünemann JD; Tintoré M; Messmer B; Strowig T; Rovira A; Perkal H; Caballero E; Münz C; Montalban X; Comabella M
Ann Neurol; 2010 Feb; 67(2):159-69. PubMed ID: 20225269
[TBL] [Abstract][Full Text] [Related]
9. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2.
Lünemann JD; Jelcić I; Roberts S; Lutterotti A; Tackenberg B; Martin R; Münz C
J Exp Med; 2008 Aug; 205(8):1763-73. PubMed ID: 18663124
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus infection: a smoking gun for multiple sclerosis?
Lucas RM; Taylor BV
Neurology; 2012 Sep; 79(13):1310-1. PubMed ID: 22933742
[No Abstract] [Full Text] [Related]
11. Antiviral immune response in patients with multiple sclerosis, healthy siblings and twins.
Ristori G; Mechelli R; Anderson J; Mengoni F; Sauzullo I; Annibali V; Cannoni S; Aloisi F; James JA; Salvetti M
Mult Scler; 2010 Dec; 16(12):1527-8. PubMed ID: 20798134
[No Abstract] [Full Text] [Related]
12. Antiviral immune response in patients with multiple sclerosis and healthy siblings.
Comabella M; Montalban X; Horga A; Messmer B; Kakalacheva K; Strowig T; Caballero E; Münz C; Lünemann J
Mult Scler; 2010 Mar; 16(3):355-8. PubMed ID: 20203149
[TBL] [Abstract][Full Text] [Related]
13. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
Lünemann JD; Edwards N; Muraro PA; Hayashi S; Cohen JI; Münz C; Martin R
Brain; 2006 Jun; 129(Pt 6):1493-506. PubMed ID: 16569670
[TBL] [Abstract][Full Text] [Related]
14. Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk.
Tengvall K; Huang J; Hellström C; Kammer P; Biström M; Ayoglu B; Lima Bomfim I; Stridh P; Butt J; Brenner N; Michel A; Lundberg K; Padyukov L; Lundberg IE; Svenungsson E; Ernberg I; Olafsson S; Dilthey AT; Hillert J; Alfredsson L; Sundström P; Nilsson P; Waterboer T; Olsson T; Kockum I
Proc Natl Acad Sci U S A; 2019 Aug; 116(34):16955-16960. PubMed ID: 31375628
[TBL] [Abstract][Full Text] [Related]
15. The beneficial effects of vitamin D3 on reducing antibody titers against Epstein-Barr virus in multiple sclerosis patients.
Najafipoor A; Roghanian R; Zarkesh-Esfahani SH; Bouzari M; Etemadifar M
Cell Immunol; 2015 Mar; 294(1):9-12. PubMed ID: 25666504
[TBL] [Abstract][Full Text] [Related]
16. [Multiple sclerosis and Epstein-Barr virus : new developments and perspectives].
Ruprecht K
Nervenarzt; 2008 Apr; 79(4):399-407. PubMed ID: 17713752
[TBL] [Abstract][Full Text] [Related]
17. Lack of replication of interaction between EBNA1 IgG and smoking in risk for multiple sclerosis.
Sundqvist E; Sundström P; Lindén M; Hedström AK; Aloisi F; Hillert J; Kockum I; Alfredsson L; Olsson T
Neurology; 2012 Sep; 79(13):1363-8. PubMed ID: 22933744
[TBL] [Abstract][Full Text] [Related]
18. Epstein-barr virus: environmental trigger of multiple sclerosis?
Lünemann JD; Kamradt T; Martin R; Münz C
J Virol; 2007 Jul; 81(13):6777-84. PubMed ID: 17459939
[No Abstract] [Full Text] [Related]
19. Epstein-Barr virus and systemic lupus erythematosus.
James JA; Harley JB; Scofield RH
Curr Opin Rheumatol; 2006 Sep; 18(5):462-7. PubMed ID: 16896283
[TBL] [Abstract][Full Text] [Related]
20. The association between anti-EBNA-1 IgG and multiple sclerosis clinical disease activity.
Bahreini SA; Zahednasab H; Saadatnia M; Jabalameli MR
Eur J Neurol; 2010 Oct; 17(10):e95; author reply e96. PubMed ID: 20636367
[No Abstract] [Full Text] [Related]
[Next] [New Search]
